HOME >> BIOLOGY >> NEWS
New Military Biomaterials R&D Center to hold first meeting

NEW BRUNSWICK/PISCATAWAY The new Center for Military Biomaterials Research (CeMBR) has been set up by the New Jersey Center for Biomaterials. The CeMBR will hold its first open meeting on Oct. 20, 2004 at 10 a.m. in the Hyatt Regency, Two Albany Street, New Brunswick, N.J.

The inaugural meeting agenda will include a summary of the science and technology roadmap created by the National Research Council to guide the Center, and discussion of potential R&D projects for the program's second year.

The CeBMR was established through the award of an initial $827,000 contract from the U.S. Army Medical Research and Materiel Command. The award is renewable for at least two years with increasing funding already provided by Congress to enable expansion of the program. This initiative will provide rapid and effective pathways for identification, development and utilization of biomaterial-based technologies and products for the military's most urgent healthcare needs on and off the battlefield.

One of the first technology platforms the CeBMR is supporting is a sprayable wound dressing designed to enable soldiers to treat their own small gunshot wounds, burns, abrasions or cuts, so that they may complete a three-day mission and rapidly return to duty. The sprayable dressing technology will then be expanded to provide pain relief, mitigate bleeding and reduce infection. Biocure, Inc. of Norcross, Ga., is developing this technology.

The CeBMR is unique among organizations active in the field because of its network of academic, military and industry leaders working to speed the introduction of biomaterial products to meet the military's requirements. This center is pursuing a "market focused" strategy of applied research, product development and commercialization of prototype products leveraged from industry and academia. When there are no existing enabling technologies that meet the military's requirements, the CeBMR will form research partne
'"/>

Contact: David Devore
devore@rutchem.rutgers.edu
732-445-0488
Rutgers, the State University of New Jersey
6-Oct-2004


Page: 1 2

Related biology news :

1. Military to study better pain relief in battle zones
2. Military bases can benefit by addressing sprawl issues and biodiversity
3. Military hazards are greater for Native Americans, according to sociological research
4. Sukhishvili invited to serve on NIHs Biomaterials and Biointerfaces Study Section
5. Psychiatric Genomics Center established at Cold Spring Harbor Laboratory
6. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
7. Woods Hole Research Center scientists study impacts of industrial logging in Central Africa
8. Innovative smallpox vaccine research study to be conducted at Case Medical Center
9. CSHL selected for odENCODE Data Coordination Center
10. Woods Hole Research Center scientists using remote sensing tools to predict bird species richness
11. NYUs Center for Comparative Functional Genomics part of $57 million MOD-ENCODE consortium

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Military Biomaterials Center hold first meeting

(Date:8/4/2015)... ) today reported financial and operating results for the second quarter ... quarter contract revenue of $ 85.2 million, a ... of 26 % , Second quarter adjusted ... royalties in the current quarter , Operating cash ... to present another strong financial quarter, with all our divisions achieving ...
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
(Date:8/31/2015)... -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... scientific review has identified high value opportunities for ... patient need. Novogen is moving as quickly as ... entering into Phase 1 clinical trials with our ... Officer, Iain Ross , said that following ...
(Date:8/31/2015)... ... August 31, 2015 , ... Regulatory agencies have ... drug development approval process. Thus, innovator companies must understand what will be needed ... Chicago-based CMO, has been hosting multiple educational panels and seminars for experts to ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zsgg5n/global_and_usa ) ... USA BioSimilar Market Analysis to 2021" report to ... market will be initiated in September as Sandoz launches ... global market react? Will biosimilars explode into the biologics ... US economy up to $250 billion within the next ...
(Date:8/28/2015)... ... 2015 , ... Riordan-McKenna Institute founders, stem cell ... the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed by Amniotic Therapies ... knee wound. , The case involved a 78-year-old male, who presented with a ...
Breaking Biology Technology:Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4
Cached News: